The biology of aging

Mount Sinai Journal of Medicine

Volumn 70, Issue 1, 2003, Pages 3-22

  Troen, Bruce R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Antagonistic pleiotropy; Cancer; Cellular; Lifespan; Mortality; Senescence

Indexed keywords

BIOLOGICAL MARKER; DNA; FREE RADICAL; MITOCHONDRIAL DNA;

AGED; AGING; CANCER PREVENTION; CELL AGING; CLINICAL OBSERVATION; DEVELOPMENTAL GENETICS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EVOLUTIONARY ADAPTATION; GENE FUNCTION; HUMAN; LIFE EXPECTANCY; LIFESPAN; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; MORTALITY; PLEIOTROPY; REPRODUCTION; REVIEW; SENESCENCE; STATISTICS; STRESS; SURVIVAL;

ADAPTATION, PHYSIOLOGICAL; AGING; ANIMALS; APOPTOSIS; CELL AGING; DNA REPAIR; EVOLUTION; HUMANS; LIFE EXPECTANCY; LONGEVITY; MODELS, THEORETICAL; OXIDATIVE STRESS; STOCHASTIC PROCESSES;

EID: 0037218826     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (219)

1. Butch Cassidy and the Sundance Kid. Http://www.filmsite.org/ butc.html; Review by Tom Dirks.
2. Anonymous. In: The Columbia world of quotations. New York: Columbia University Press; 1996.
3. Daniel Francois Esprit Auber. In: Bloomsbury biographic dictionary of quotations. London (UK): Bloomsbury; 1997; Http://www.bloomsburymagazine.com
4. Cutler RG. Evolutionary perspective of human longevity. In: Hazzard WR, Andres R, Bierman EL, Blass JP, editors. Principles of geriatric medicine and gerontology. New York: McGraw-Hill, 1990. pp. 15-21.
5. Monthly Vital Statistics Report. Hyattsville (MD): National Center for Health Statistics; 1997 June 12. No. 11(S)2. Vol. 45.
6. Sixty-five plus in the United States. Bureau of the Census Statistical Brief, U.S. Department of Commerce. May 1995. SB/ 95-8.
7. Roush W. Live long and prosper? [news]. Science 1996; 273:42-46.
8. Greville TN, Bayo F, Foster R. United States life tables by causes of death: 1960-1971. Hyattsville (MD): Technical Report - DHEW Publication. 1975 May. Publication #75/ 1150-Vol-1-5.
9. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273:59-63.
10. Weindruch R, Walford RL. Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science 1982; 215:1415-1418.
11. Yu BP, Masoro EJ, McMahan CA. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics. J Gerontol 1985; 40:657-670.
12. Masoro EJ. Dietary restriction and aging. J Am Geriatr Soc 1993; 41:994-999.
13. Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 1997; 337:986-994.
14. Dulloo AG, Girardier L. 24 hour energy expenditure several months after weight loss in the underfed rat: evidence for a chronic increase in whole-body metabolic efficiency. Int J Obes Relat Metab Disord 1993; 17:115-123.
15. Gonzales-Pacheco DM, Buss WC, Koehler KM, et al. Energy restriction reduces metabolic rate in adult male Fisher-344 rats. J Nutr 1993; 123:90-97.
16. McCarter R, Masoro EJ, Yu BP. Does food restriction retard aging by reducing the metabolic rate? Am J Physiol 1985; 248:E488-E490.
17. Lane MA, Baer DJ, Rumpler WV, et al. Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents. Proc Natl Acad Sci U S A 1996; 93:4159-4164.
18. Ramsey JJ, Roecker EB, Weindruch R, Kemnitz JW. Energy expenditure of adult male rhesus monkeys during the first 30 mo of dietary restriction. Am J Physiol 1997; 272(5 Pt 1):E901-E907.
19. Verdery RB, Ingram DK, Roth GS, Lane MA. Caloric restriction increases HDL2 levels in rhesus monkeys (Macaca mulatta). Am J Physiol 1997; 273:E714-E719.
20. Lane MA, Ingram DK, Ball SS, Roth GS. Dehydroepiandrosterone sulfate: a biomarker of primate aging slowed by calorie restriction. J Clin Endocrinol Metab 1997; 82: 2093-2096.
21. Gompertz B. On the nature of the function expressive of the law of human mortality and on a new mode of determining life contingencies. Philos Trans R Soc Lond 1825; 115: 513-585.
22. Rosenberg HM, Ventura SJ, Maurer JD, et al. Births and deaths: United States, 1995. Monthly Vital Statistics Report 1996; 45:31-33.
23. Kaeberlein M, McVey M, Guarente L. Using yeast to discover the fountain of youth. In: Science of aging and knowledge environment. Washington (DC): American Association for the Advancement of Science; New Findings Perspectives; 2001; http://sageke.sciencemag.org/cgi/content/full/sageke; 2001/1/pel
24. Shock NW, Greulich RC, Andres R, et al. Normal human aging: the Baltimore longitudinal study of aging. Washington (DC): Department of Health and Human Services (US); 1984. NIH Publication No. 84-2450.
25. Riggs BL, Melton LD. Involutional osteoporosis. N Engl J Med 1986; 314:16761-16786.
26. Florini JR, editor. Composition and function of cells and tissues. Handbook of biochemistry in aging. Boca Raton (FL): CRC Press; 1981.
27. Strehler BL. Time, cells, and aging. New York: Academic Press; 1977.
28. Bjorksten J. Cross linkage and the aging process. In: Rothstein M, editor. Theoretical aspects of aging. New York: Academic Press; 1974. pp. 43-60.
29. Kohn RR. Aging of animals: possible mechanisms. In: Kohn RR, editor. Principles of mammalian aging. Englewood Cliffs (NJ): Prentice-Hall; 1978.
30. Finch CE. Introduction: definitions and concepts. In: Finch CE. Longevity, senescence, and the genome. Chicago: University of Chicago Press; 1990.
31. Schneider EL, Rowe JW, editors. Handbook of the biology of aging. San Diego (CA): Academic Press; 1996.
32. Shock NW. Longitudinal studies of aging in humans. In: Finch CE, Schneider EL, editors. Handbook of the biology of aging. New York: Van Nostrand Reinhold; 1985. p. 721.
33. Lakatta EG. Changes in cardiovascular function with aging. Eur Heart J 1990; (11 Suppl C):22-29.
34. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278-285.
35. Adelman RC, Britton GW, Rotenberg S, et al. Endocrine regulation of gene activity in aging animals of different genotypes. In: Bergsma D, Harrison DE, editors. Genetic effects on aging. New York: Alan R. Liss; 1978. p. 355.
36. Brody JA, Brock DB. Epidemiological and statistical characteristics of the United States elderly population. In: Finch CE, Schneider EL, editors. Handbook of the biology of aging. New York: Van Nostrand Reinhold; 1985. p. 3.
37. Hitt R, Young-Xu Y, Silver M, Perls T. Centenarians: the older you get, the healthier you have been. Lancet 1999; 354:652.
38. Rose MR, Graves JL, Jr. What evolutionary biology can do for gerontology. J Gerontol 1989; 44:B27-B29.
39. Kirkwood TB, Rose MR. Evolution of senescence: late survival sacrificed for reproduction. Philos Trans R Soc Lond B Biol Sci 1991; 332:15-24.
40. Kirkwood TB. Human senescence. Bioessays 1996; 18:1009-1016.
41. Failla G. The aging process and carcinogenesis. Ann N Y Acad Sci 1958; 71:1124-1140.
42. Szilard L. On the nature of the aging process. Proc Natl Acad Sci U S A 1959; 45:30-45.
43. Walburg HE. Radiation-induced life-shortening and premature aging. Advances in Radiation Biology 1975; 5:145-179.
44. Sacher CA. Life table modification and life prolongation. In: Finch CE, Hayflick L, editors. Handbook of the biology of aging. New York: Van Nostrand Reinhold; 1977. pp. 582-638.
45. Lindop PJ, Rotblat J. Life-shortening in mice exposed to radiation: effects of age and of hypoxia. Nature 1965; 208(15):1070-1072.
46. Hart RW, Setlow RB. Correlation between deoxyribonucleic acid excision-repair and life- span in a number of mammalian species. Proc Natl Acad Sci U S A 1974; 71: 2169-2173.
47. Hanawalt PC, Gee P, Ho L, et al. Genomic heterogeneity of DNA repair. Role in aging? Ann N Y Acad Sci 1992; 663: 17-25.
48. Orgel LE. The maintenance of the accuracy of protein synthesis and its relevance to aging. Proc Natl Acad Sci U S A 1963; 49:517-521
49. Kristal BS, Yu BP. An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions. J Gerontol 1992; 47:B107-B114.
50. Levine RL, Stadtman ER. Protein modifications with aging. In: Schneider EL, Rowe JW, editors. Handbook of the biology of aging. San Diego (CA): Academic Press; 1996. pp. 184-197.
51. Gracy RW, Yuksel KU, Chapman MD, et al. Impaired protein degradation may account for the accumulation of "abnormal" proteins in aging cells. In: Adelman RC, Dekker EE, editors. Modern aging research, modification of proteins during aging. New York: Alan R. Liss; 1985. pp. 1-18.
52. Reiser KM, Hennessy SM, Last JA. Analysis of age-associated changes in collagen crosslinking in the skin and lung in monkeys and rats. Biochim Biophys Acta 1987; 926: 339-348.
53. Hall DA. Chemical and biochemical changes in aging connective tissues. The aging of connective tissue. New York: Academic Press; 1976.
54. Chavous DA, Jackson FR, O'Connor CM. Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc Natl Acad Sci U S A 2001; 98: 14814-14818.
55. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.
56. Harman D. The aging process. Proc Natl Acad Sci U S A 1981; 78:7124-7128.
57. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem 1989; 264:7761-7764.
58. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription [see comments]. FASEB J 1996; 10:709-720.
59. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22: 269-285.
60. Sohal RS, Svensson J, Sohal BH, Brunk UT. Superoxide anion radical production in different animal species. Mech Ageing Dev 1989; 49:129-135.
61. Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994; 263:1128-1130.
62. Linnane AW, Zhang C, Baumer A, Nagley P. Mitochondrial DNA mutation and the ageing process: bioenergy and pharmacological intervention. Mutat Res 1992; 275:195-208.
63. Fleming JE, Miquel J, Cottrell SF, et al. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 1982; 28:44-53.
64. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256:628-632.
65. Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol Rev 1997; 77:425-464.
66. Katayama M, Tanaka M, Yamamoto H, et al. Deleted mitochondrial DNA in the skeletal muscle of aged individuals. Biochem Int 1991; 25:47-56.
67. Lee CM, Chung SS, Kaczkowski JM, et al. Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. J Gerontol 1993; 48:B201-B215.
68. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle [published erratum appears in Nucleic Acids Res 1995 Dec 11;23(23):4938]. Nucleic Acids Res 1995; 23:4122-4126.
69. Torii K, Sugiyama S, Tanaka M, et al. Aging-associated deletions of human diaphragmatic mitochondrial DNA. Am J Respir Cell Mol Biol 1992; 6:543-549.
70. Hayakawa M, Torii K, Sugiyama S, et al. Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm. Biochem Biophys Res Commun 1991; 179:1023-1029.
71. Sugiyama S, Hattori K, Hayakawa M, Ozawa T. Quantitative analysis of age-associated accumulation of mitochondrial DNA with deletion in human hearts. Biochem Biophys Res Commun 1991; 180:894-899.
72. Hayakawa M, Katsumata K, Yoneda M, et al. Age-related extensive fragmentation of mitochondrial DNA into minicircles [published erratum appears in Biochem Biophys Res Commun 1997 Mar 27;232(3):832]. Biochem Biophys Res Commun 1996; 226:369-377.
73. Hayakawa M, Hattori K, Sugiyama S, Ozawa T. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun 1992; 189:979-985.
74. Hayakawa M, Sugiyama S, Hattori K, et al. Age-associated damage in mitochondrial DNA in human hearts. Mol Cell Biochem 1993; 119:95-103.
75. Ikebe S, Tanaka M, Ohno K, et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990; 170: 1044-1048.
76. Corral-Debrinski M, Horton T, Lott MT, et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 1992; 2:324-329.
77. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing [see comments]. Lancet 1989; 1:637-639.
78. Schapira AH, Mann VM, Cooper JM, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990; 55: 2142-2145.
79. Schapira AH, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54:823-827.
80. Hoyer S. Senile dementia and Alzheimer's disease. Brain blood flow and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10:447-478.
81. Sims NR, Finegan JM, Blass JP, et al. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 1987; 436:30-38.
82. Beal MF. Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 1994; 7:542-547.
83. Schulz JB, Beal MF. Mitochondrial dysfunction in movement disorders. Mech Dev 1996; 57:3-20.
84. Lin FH, Lin R, Wisniewski HM, et al. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 1992; 182:238-246.
85. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993; 17:171-184.
86. Ozawa T, Tanaka M, Ino H, et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun 1991; 176:938-946.
87. Ozawa T, Tanaka M, Ikebe S, et al. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem Biophys Res Commun 1990; 172:483-489.
88. Ikebe S, Tanaka M, Ozawa T. Point mutations of mitochondrial genome in Parkinson's disease. Brain Res Mol Brain Res 1995; 28:281-295.
89. Poulton J, Deadman ME, Ramacharan S, Gardiner RM. Germline deletions of mtDNA in mitochondrial myopathy. Am J Hum Genet 1991; 48:649-653.
90. Ionasescu VV, Hart M, DiMauro S, Moraes CT. Clinical and morphologic features of a myopathy associated with a point mutation in the mitochondrial tRNA(Pro) gene. Neurology 1994; 44:975-977.
91. Ozawa T, Tanaka M, Sugiyama S, et al. Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy. Biochem Biophys Res Commun 1991; 177:518-525.
92. Katsumata K, Hayakawa M, Tanaka M, et al. Fragmentation of human heart mitochondrial DNA associated with premature aging. Biochem Biophys Res Commun 1994; 202:102-110.
93. Ozawa T. Mitochondrial cardiomyopathy. Herz 1994; 19: 105-125.
94. Yoneda M, Katsumata K, Hayakawa M, et al. Oxygen stress induces an apoptotic cell death associated with fragmentation of mitochondrial genome. Biochem Biophys Res Commun 1995; 209:723-729.
95. Melov S, Hinerfeld D, Esposito L, Wallace DC. Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Res 1997; 25:974-982.
96. De Benedictis G, Rose G, Carrieri G, et al. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 1999; 13:1532-1536.
97. Rose G, Passarino G, Carrieri G, et al. Paradoxes in longevity: sequence analysis of mtDNA haplogroup J in centenarians. Eur J Hum Genet 2001; 9:701-707.
98. Ross OA, McCormack R, Curran MD, et al. Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp Gerontol 2001; 36:1161-1178.
99. Larsen PL, Clarke CF. Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q. Science 2002; 295: 120-123.
100. Zainal TA, Oberley TD, Allison DB, et al. Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J 2000; 14:1825-1836.
101. Meydani M. Nutrition interventions in aging and age-associated disease. Ann N Y Acad Sci 2001; 928:226-235.
102. Finch CE, Tanzi RE. Genetics of aging. Science 1997; 278: 407-411.
103. Jazwinski SM. Longevity, genes, and aging. Science 1996; 273:54-59.
104. Murakami S, Johnson TE. A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans. Genetics 1996; 143:1207-1218.
105. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans [see comments]. Science 1997; 277:942-946.
106. Kenyon C, Chang J, Gensch E, et al. A C. elegans mutant that lives twice as long as wild type [see comments]. Nature 1993; 366:461-464.
107. Lin K, Dorman JB, Rodan A, Kenyon C. daf-16: an HNF-3/forkhead family member that can function for double the life-span of Caenorhabditis elegans. Science 1997; 278: 1319-1322.
108. Lin YJ, Seroude L, Benzer S. Extended life-span and stress resistance in the Drosophila mutant Methuselah. Science 1998; 282:943-946.
109. Rogina B, Reenan RA, Nilsen SP, Helfand SL. Extended lifespan conferred by cotransporter gene mutations in Drosophila. Science 2000; 290:2137-2140.
110. Dudas SP, Arking R. A coordinate upregulation of antioxidant gene activities is associated with the delayed onset of senescence in a long-lived strain of Drosophila. J Gerontol A Biol Sci Med Sci 1995; 50:B117-B127.
111. Rose MR, Vu LN, Park SU, Graves JL, Jr. Selection on stress resistance increases longevity in Drosophila melanogaster. Exp Gerontol 1992; 27:241-250.
112. Lithgow GJ, Andersen JK. The real Dorian Gray mouse. Bioessays 2000; 22:410-413.
113. Flurkey K, Papaconstantinou J, Harrison DE. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech Ageing Dev 2002; 123:121-130.
114. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6:29-32.
115. Perls T, Levenson R, Regan M, Puca A. What does it take to live to 100? Mech Ageing Dev 2002; 123:231-242.
116. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999; 285:1390-1393.
117. Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet 2000; 25:294-297.
118. Kayo T, Allison DB, Weindruch R, Prolla TA. Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc Natl Acad Sci U S A 2001; 98:5093-5098.
119. Weindruch R, Kayo T, Lee CK, Prolla TA. Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. J Nutr 2001; 131:918S-923S.
120. Turker MS, Martin GM. Genetics of human disease, longevity and aging. In: Hazzard WR, Blass JP, Ettinger WH, Jr, Halter JB, editors. Principles of geriatric medicine and gerontology. 4th ed. London: McGraw-Hill; 1999. pp. 21-44.
121. Brown WT. Genetic diseases of premature aging as models of senescence. Annu Rev Gerontol Geriatr 1990; 10:23-42.
122. Goto M, Rubenstein M, Weber J, et al. Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature 1992; 355:735-738.
123. Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner's syndrome gene [see comments]. Science 1996; 272:258-262.
124. Kuro-o M. Disease model: human aging. Trends Mol Med 2001; 7:179-181.
125. Mobbs CV. Neuroendocrinology of aging. In: Schneider EL, Rowe JW, editors. Handbook of the biology of aging. San Diego (CA): Academic Press, 1996. pp. 234-282.
126. Wise PM, Krajnak KM, Kashon ML. Menopause: the aging of multiple pacemakers. Science 1996; 273:67-70.
127. Denckla WD. A time to die. Life Sci 1975; 16:31-44.
128. Gilad GM, Gilad VH. Age-related reductions in brain cholinergic and dopaminergic indices in two rat strains differing in longevity. Brain Res 1987; 408:247-250.
129. Cotzias GC, Miller ST, Tang LC, Papavasiliou PS. Levodopa, fertility, and longevity. Science 1977; 196:549-551.
130. Knoll J. (-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system. J Am Geriatr Soc 1992; 40:839-847.
131. Kitani K, Kanai S, Sato Y, et al. Chronic treatment of deprenyl prolongs the life span of male Fischer 344 rats. Further evidence. Life Sci 1993; 52:281-288.
132. Milgram NW, Racine RJ, Nellis P, et al. Maintenance on L-deprenyl prolongs life in aged male rats. Life Sci 1990; 47: 415-420.
133. Walford RL. Immunologic theory of aging: current status. Fed Proc 1974; 33:2020-2027.
134. Miller RA. The aging immune system: primer and prospectus. Science 1996; 273:70-74.
135. Yunis EJ, Salazar M. Genetics of life span in mice. Genetica 1993; 91:211-223.
136. Caruso C, Candore G, Romano GC, et al. Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data. Mech Ageing Dev 2001; 122: 445-462.
137. Hayflick L, Moorhead PS. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37:614-636.
138. Bayreuther K, Rodemann HP, Hommel R, et al. Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci U S A 1988; 85:5112-5116.
139. Pignoto RJ, Rotenberg MO, Cristofalo VJ. Alterations in contact and density-dependent arrest state in senescent WI-38 cells. In Vitro Cell Dev Biol Amin 1994; 30A:471-476.
140. Matsumura T, Zerrudo Z, Hayflick L. Senescent human diploid cells in culture: survival, DNA synthesis and morphology. J Gerontol 1979; 34:328-334.
141. Cristofalo VJ, Palaxxo R, Charpentier RL. Limited lifespan of human fibroblasts in vitro: metabolic time or replications? In: Adelman RC, Roberts J, Baker GT, et al., editors. Neural regulatory mechanisms during aging. New York: Alan R. Liss; 1980. pp. 203-206.
142. Ponten J, Stein WD, Shall S. A quantitative analysis of the aging of human glial cells in culture. J Cell Physiol 1983; 117(3):342-352.
143. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6:331-343.
144. Bierman EL. The effect of donor age on the in vitro life span of cultured human arterial smooth-muscle cells. In Vitro 1978; 14:951-955.
145. Tassin J, Malaise E, Courtois Y. Human lens cells have an in vitro proliferative capacity inversely proportional to the donor age. Exp Cell Res 1979; 123:388-392.
146. Mueller SN, Rosen EM, Levine EM. Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science 1980; 207:889-891.
147. Tice RR, Schneider EL, Kram D, Thorne P. Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin. J Exp Med 1979; 149:1029-1041.
148. Harrison DE. Cell and tissue transplantation: a means of studying the aging process. In: Finch CE, Schneider EL, editors. Handbook of the biology of aging. New York: Van Nostrand Reinhold; 1985. p. 332-356.
149. Olsson L, Ebbesen P. Ageing decreases the activity of epidermal G1 and G2 inhibitors in mouse skin independent of grafting on old or young recipients. Exp Gerontol 1977; 12: 59-62.
150. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci U S A 1981; 78:5009-5013.
151. Martin GM, Sprague CA, Epstein CJ. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest 1970; 23:86-92.
152. Pignolo RJ, Masoro EJ, Nichols WW, et al. Skin fibroblasts from aged Fischer 344 rats undergo similar changes in replicative life span but not immortalization with caloric restriction of donors. Exp Cell Res 1992; 201:16-22.
153. Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A 1976; 73:3584-3588.
154. Le Guilly Y, Simon M, Lenoir P, Bourel M. Long-term culture of human adult liver cells: morphological changes related to in vitro senescence and effect of donor's age on growth potential. Gerontologia 1973; 19:303-313.
155. Wille JJ, Jr., Pittelkow MR, Shipley GD, Scott RE. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol 1984; 121:31-44.
156. Cristofalo VJ, Allen RG, Pignolo RJ, et al. Relationship between donor age and the replicative life span of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A 1998; 95:10614-10619.
157. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-9367.
158. Severino J, Allen RG, Balin S, et al. Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Exp Cell Res 2000; 257:162-171.
159. Rubin H. Cell aging in vivo and in vitro. Mech Ageing Dev 1997; 98:1-35.
160. Troen BR, Cristofalo VJ. Cell and molecular aging. In: Rosenthal RA, Zenilman ME, Katlic MR, editors. Principles and practice of geriatric surgery. New York: Springer; 2001. pp. 8-23.
161. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256:271-282.
162. Greider CW. Telomeres, telomerase and senescence. Bioessays 1990; 12:363-369.
163. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-460.
164. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992; 89:10114-10118.
165. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995; 92: 11190-11194.
166. Lindsey J, McGill NI, Lindsey LA, et al. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991; 256: 45-48.
167. Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52:661-667.
168. Frenck RW, Jr., Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A 1998; 95:5607-5610.
169. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma [see comments]. Proc Natl Acad Sci U S A 1994; 91:2900-2904.
170. Sugihara S, Mihara K, Marunouchi T, et al. Telomere elongation observed in immortalized human fibroblasts by treatment with 60Co gamma rays or 4-nitroquinoline 1-oxide. Hum Genet 1996; 97:1-6.
171. Bryan TM, Englezou A, Gupta J, et al. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14:4240-4248.
172. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996; 14:239-248.
173. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995; 92:9082-9086.
174. Counter CM, Gupta J, Harley CB, et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85:2315-2320.
175. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107:67-77.
176. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 1996; 15: 1734-1741.
177. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of lifespan by introduction of telomerase into normal human cells [see comments]. Science 1998; 279:349-352.
178. Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999; 96:701-712.
179. Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc, 1997; 45:482-488.
180. Shay JW, Wright WE, Werbin H. Toward a molecular understanding of human breast cancer: a hypothesis. Breast Cancer Res Treat 1993; 25:83-94.
181. Atadja P, Wong H, Garkavtsev I, et al. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci U S A 1995; 92: 8348-8352.
182. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990; 249:666-699.
183. Ozer HL, Banga SS, Dasgupta T, et al. SV40-mediated immortalization of human fibroblasts. Exp Gerontol 1996; 31: 303-310.
184. Shay JW, Pereira-Smith 0M, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196:33-39.
185. Hara E, Tsurui H, Shinozaki A, et al. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 1991; 179:528-534.
186. Afshari CA, Nichols MA, Xiong Y, Mudryj M. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ 1996; 7:979-988.
187. Noda A, Ning Y, Venable SF, et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211:90-98.
188. Tahara H, Sato E, Noda A, Ide T. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 1995; 10:835-840.
189. Alcorta DA, Xiong Y, Phelps D, et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 1996; 93:13742-13747.
190. Palmero I, McConnell B, Parry D, et al. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 1997; 15:495-503.
191. Reznikoff CA, Yeager TR, Belair CD, et al. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 1996; 56:2886-2890.
192. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277:831-834.
193. Yang L, Didenko VV, Noda A, et al. Increased expression of p21Sdi1 in adrenocortical cells when they are placed in culture. Exp Cell Res 1995; 221:126-131.
194. Medcalf AS, Klein-Szanto AJ, Cristofalo VJ. Expression of p21 is not required for senescence of human fibroblasts. Cancer Res 1996; 56:4582-4585.
195. Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602.
196. Vogt M, Haggblom C, Yeargin J, et al. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ 1998; 9: 139-146.
197. Afshari CA, Vojta PJ, Annab LA, et al. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp Cell Res 1993; 209:231-237.
198. Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001; 13:332-337.
199. Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97: 527-538.
200. Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402:309-313.
201. Ferbeyre G, Lowe SW. The price of tumour suppression? Nature 2002; 415:26-27.
202. Tyner SD, Venkatachalam S, Choi J, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415:45-53.
203. Campisi J. Cancer and aging: Yin, yang, and p53. Science of aging and knowledge environment: American Association for the Advancement of Science and Science Magazine; 2002; http://sageke.sciencemag.org/cgi/content/full/sageke; 2001/1/pel
204. Krtolica A, Parrinello S, Lockett S, et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 2001; 98:12072-12077.
205. Lockshin RA, Zakeri Z. Programmed cell death and apoptosis. In: Tomei LD, Cope FO, editors. Apoptosis: the molecular basis of cell death. Plainview (NY): Cold Spring Harbor Laboratory Press; 1991. pp. 47-60.
206. Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Anna Rev Cell Dev Biol 1991; 7:663-698.
207. Yuan JY, Horvitz HR. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol 1990; 138:33-41.
208. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76:665-676.
209. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-365.
210. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10:1-15.
211. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res 1995; 55:2284-2292.
212. Suh Y, Lee KA, Kim WH, et al. Aging alters the apoptotic response to genotoxic stress. Nat Med 2002; 8:3-4.
213. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, et al. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci U S A 1994; 91:9995-9999.
214. James SJ, Muskhelishvili L. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6 x C3H F1 mice. Cancer Res 1994; 54:5508-5510.
215. Warner HR, Fernandes G, Wang E. A unifying hypothesis to explain the retardation of aging and tumorigenesis by caloric restriction. J Gerontol A Biol Sci Med Sci 1995; 50: B017-B109.
216. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88:347-354.
217. Luan X, Zhao W, Chandrasekar B, Fernandes G. Calorie restriction modulates lymphocyte subset phenotype and increases apoptosis in MRL/1pr mice. Immunol Lett 1995; 47:181-186.
218. Zhou T, Edwards CK, Mountz JD. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice [see comments]. J Exp Med 1995; 182:129-137.
219. Warner HR, Hodes RJ, Pocinki K. What does cell death have to do with aging? J Am Geriatr Soc 1997; 45:1140-1146.